B7-H3-IMT-R5 checkpoint inhibitor (TrueBinding)

N/A

Report date: 2025/03/14 18:11:16

Base Information

Drug NameB7-H3-IMT-R5 checkpoint inhibitor (TrueBinding)
Drug Alias NameIMT-R5-B7-H3 checkpoint inhibitor (TrueBinding)anti B7-H3-IMT-R5 antibody (Immutics)anti B7-H3-IMT-R5 antibody (TrueBinding)B7-H3-IMT-R5 checkpoint inhibitor (Immutics)IMT-R5-B7-H3 checkpoint inhibitor (Immutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCD276 antigen inhibitors
TargetsCD276 antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTrueBinding Inc
China Registration ClassN/A

Develop Information

Active CompaniesTrueBinding Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A